EPS for ICU Medical, Inc. (ICUI) Expected At $1.68

ICU Medical, Inc. (NASDAQ:ICUI) Logo
Investors sentiment decreased to 1.38 in 2018 Q3. Its down 0.09, from 1.47 in 2018Q2. It is negative, as 24 investors sold ICU Medical, Inc. shares while 88 reduced holdings. 54 funds opened positions while 100 raised stakes. 14.77 million shares or 0.05% less from 14.78 million shares in 2018Q2 were reported.
First Fin In has 0.04% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 200 shares. State Treasurer State Of Michigan holds 0.01% or 6,100 shares in its portfolio. Mason Street Advsrs Limited Co reported 8,515 shares stake. Tci Wealth Advsrs reported 0% in ICU Medical, Inc. (NASDAQ:ICUI). Kennedy Cap Mgmt Inc holds 72,229 shares. Us Bancshares De has 0.01% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 9,661 shares. Eqis Management Incorporated invested in 0.03% or 1,412 shares. Patten Gru accumulated 41 shares. Silvercrest Asset Ltd owns 187,891 shares. Moreover, Eaton Vance Management has 0.07% invested in ICU Medical, Inc. (NASDAQ:ICUI). Globeflex Capital Lp holds 0.61% or 11,011 shares. Hbk Investments L P stated it has 26,800 shares. Missouri-based Scout Investments Inc has invested 0.21% in ICU Medical, Inc. (NASDAQ:ICUI). American Group reported 33,778 shares or 0.03% of all its holdings. Northwestern Mutual Wealth Mgmt Com holds 17 shares or 0% of its portfolio.

Since August 13, 2018, it had 0 buys, and 4 selling transactions for $527.10 million activity. McCall Thomas D also sold $3.37M worth of ICU Medical, Inc. (NASDAQ:ICUI) shares. Sanzone Virginia Ruth sold 787 shares worth $238,555. $363,285 worth of ICU Medical, Inc. (NASDAQ:ICUI) was sold by SWINNEY ROBERT S on Monday, January 28.

Analysts expect ICU Medical, Inc. (NASDAQ:ICUI) to report $1.68 EPS on March, 7.They anticipate $1.02 EPS change or 37.78 % from last quarter’s $2.7 EPS. ICUI’s profit would be $34.42M giving it 37.27 P/E if the $1.68 EPS is correct. After having $1.56 EPS previously, ICU Medical, Inc.’s analysts see 7.69 % EPS growth. The stock increased 1.51% or $3.73 during the last trading session, reaching $250.44. About 116,049 shares traded. ICU Medical, Inc. (NASDAQ:ICUI) has risen 11.09% since February 12, 2018 and is uptrending. It has outperformed by 11.09% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $5.13 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics. It has a 63.1 P/E ratio. The company's infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

More notable recent ICU Medical, Inc. (NASDAQ:ICUI) news were published by: Globenewswire.com which released: “ICU Medical, Inc. Announces First Quarter 2018 Results – GlobeNewswire” on May 09, 2018, also Seekingalpha.com with their article: “ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” published on August 10, 2018, Nasdaq.com published: “Noteworthy Thursday Option Activity: YELP, ICUI, ATHN – Nasdaq” on November 08, 2018. More interesting news about ICU Medical, Inc. (NASDAQ:ICUI) were released by: Globenewswire.com and their article: “ICU Medical, Inc. Announces Second Quarter 2018 Results – GlobeNewswire” published on August 09, 2018 as well as Nasdaq.com‘s news article titled: “After-Hours Earnings Report for August 9, 2018 : MCHP, INVH, ICUI, NWSA, OLED, AL, TARO, AQN, PLNT, JCOM, VSAT, RBA – Nasdaq” with publication date: August 09, 2018.

ICU Medical, Inc. (NASDAQ:ICUI) Institutional Positions Chart